News & Trends - MedTech & Diagnostics
College of Pathologists strongly recommends to conserve lab swabs for urgent COVID-19 tests
Due to a limited supply, the Royal College of Pathologists of Australasia (RCPA) is calling for all clinicians, GPs and healthcare providers to conserve the utilisation of all lab swabs, by limiting any unnecessary or non-urgent testing, such as for chronic leg ulcers.
Dr Michael Dray, President of the Royal College of Pathologists of Australasia said, “It is essential that the use of all swabs is conserved to critical testing only. Currently, swabs should only be utilised for the testing of COVID-19 where they meet testing criteria, and for other urgent conditions.
“It is important to acknowledge that laboratories are working at high capacity during this period of increased demand, therefore, we seek the assistance of our healthcare colleagues to ensure that all tests are prioritised as much as possible.
Register FREE and join 20,000+ industry professionals receiving the latest industry news and engaging content from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals.
“Pathologists and Scientists are playing a critical role during this pandemic, as they work around the clock to deliver high-quality testing within short timeframes, whilst testing for and diagnosing COVID-19. The RCPA continues to be dedicated to ensuring that patients receive only the highest levels of care and receive the highest standards of quality testing, in order to ensure optimal patient outcomes.”
The RCPA is the leading organisation representing pathologists in Australasia and will continue to support pathologists and improve the use of pathology testing to achieve better healthcare in the community.
Digital & Innovation
Meta finally admits to exploiting Aussie data for AI training: Call for privacy law reforms
Digital & Innovation: Facebook uses photos, posts and data from its adult Australian users to train AI models, Meta’s global […]
MoreNews & Trends - MedTech & Diagnostics
Policymakers undergo diabetes health check as push for equitable access to medical technologies escalates
MedTech News: Policymakers at Parliament House underwent a comprehensive health check yesterday, including assessments for HbA1c, cholesterol, blood pressure, and […]
MoreNews & Trends - Pharmaceuticals
Diabetes drugs underused in Australia despite proven benefits, study reveals
Pharma News: A new analysis has revealed that more Australians with type 2 diabetes should have access to potentially lifesaving […]
MoreNews & Trends - MedTech & Diagnostics
Landmark funding to expand genomic testing and precision medicine access for Victorian cancer patients
Diagnostics News: A landmark funding contribution will establish an advanced genomic testing program in Victoria, aiming to deliver personalised, precision […]
More